TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Applications Sought to Develop Tools for Zebrafish Research

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) encourages grant applications to develop tools for Zebrafish research. This announcement is made together with 16 other components of the National Institutes of Health (NIH).*

The objective of this program announcement is to continue to broaden the range, power, and utility of tools for biomedical and behavioral research using Zebrafish, and to develop genetic and genomic resources of high priority to the Zebrafish community.

Areas of research interest include, but are not limited to: research on the development, normal function, and diseases of the nervous system; the use of mutants as models for neurodegenerative diseases for use in translational research; development and/or application of novel methods of mutagenesis; development of techniques supporting more efficient targeting of induced local lesions in genomes (TILLING); development of technologies for gene inactivation and for gene expression manipulation; development of high throughput small molecule screens; development of new genetic or genomic resources that are of high priority for the Zebrafish community; development and/or application of novel screens for mutants; screens focusing on identifying novel developmental genes and pathways; and screens to analyze the genetic basis of adult phenotypes.

For more information, potential applicants should contact Dr. Danilo Tagle, Program Director, Neurogenetics Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2133, Bethesda, MD 20892; telephone: 301-496-5745; fax: 301-402-1501; e-mail:

*For a full list of supporting NIH components and a more detailed description of this program announcement, please visit the NIH web site at: